Skip to search formSkip to main contentSkip to account menu

LMI1195

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background18F-N-[3-bromo-4-(3-fluoro-propoxy)-benzyl]-guanidine (18F-LMI1195) is a new class of PET tracer designed for… 
Review
2017
Review
2017
Cardiac sympathetic nervous activity can be uniquely visualized by non-invasive radionuclide imaging techniques due to the fast… 
Highly Cited
2015
Highly Cited
2015
18F-N-[3-bromo-4-(3-fluoro-propoxy)-benzyl]-guanidine (18F-LMI1195) is a new PET tracer designed for noninvasive assessment of… 
Highly Cited
2014
Highly Cited
2014
A novel 18F-labeled ligand for the norepinephrine transporter (N-[3-bromo-4-(3-18F-fluoro-propoxy)-benzyl]-guanidine [LMI1195… 
2013
2013
A novel 18F-labeled tracer, LMI1195 (N-[3-bromo-4-(3-18F-fluoro-propoxy)-benzyl]-guanidine), is being developed for sympathetic… 
2012
2012
PurposeRegional cardiac sympathetic denervation (RCSD) associated with reduced noradrenaline transporter (NAT) function has been… 
Highly Cited
2011
Highly Cited
2011
Background—Heart failure has been associated with impaired cardiac sympathetic neuronal function. Cardiac imaging with… 
2011
2011
Background—Heart failure has been associated with impaired cardiac sympathetic neuronal function. Cardiac imaging with… 
2009
2009
LMI1195 is a new 18F-benzylguanidine analog being developed to assess cardiac neuronal function by targeting the norepinephrine…